Diego Based Neomorph News Today

socaltech.com San Diego-based Neomorph, a biotech startup focused on protein degradation, said today that it has raised $109M in a Series A funding. The funding came from Deerfield Management. The company said its targeted protein degradation technology is aimed at developing novel therapeutics across a broad range of disease areas, including oncology. The companys scientific founders are Phil Chamberlain, DPhil; Eric Fischer, PhD; Benjamin Ebert, MD, PhD; and Scott Armstrong, MD, PhD. The com...